MA44131A - Dérivés de 1-(3-tert-butyl-2h-pyrazol-5-yl or 5-tert-butyl-isoxaol-3-yl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro-naphthalenyl) urée et leur utlisation en tant qu'inhibiteurs de p38 mapk - Google Patents

Dérivés de 1-(3-tert-butyl-2h-pyrazol-5-yl or 5-tert-butyl-isoxaol-3-yl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro-naphthalenyl) urée et leur utlisation en tant qu'inhibiteurs de p38 mapk

Info

Publication number
MA44131A
MA44131A MA044131A MA44131A MA44131A MA 44131 A MA44131 A MA 44131A MA 044131 A MA044131 A MA 044131A MA 44131 A MA44131 A MA 44131A MA 44131 A MA44131 A MA 44131A
Authority
MA
Morocco
Prior art keywords
tert
butyl
isoxaol
naphthalenyl
triazolo
Prior art date
Application number
MA044131A
Other languages
English (en)
Inventor
Elisabetta Armani
Carmelida Capaldi
Christopher Hurley
Andrew Stephen Robert Jennings
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of MA44131A publication Critical patent/MA44131A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA044131A 2015-12-23 2016-12-20 Dérivés de 1-(3-tert-butyl-2h-pyrazol-5-yl or 5-tert-butyl-isoxaol-3-yl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro-naphthalenyl) urée et leur utlisation en tant qu'inhibiteurs de p38 mapk MA44131A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15202350 2015-12-23

Publications (1)

Publication Number Publication Date
MA44131A true MA44131A (fr) 2021-05-26

Family

ID=55024005

Family Applications (1)

Application Number Title Priority Date Filing Date
MA044131A MA44131A (fr) 2015-12-23 2016-12-20 Dérivés de 1-(3-tert-butyl-2h-pyrazol-5-yl or 5-tert-butyl-isoxaol-3-yl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro-naphthalenyl) urée et leur utlisation en tant qu'inhibiteurs de p38 mapk

Country Status (5)

Country Link
US (1) US9758521B2 (fr)
EP (1) EP3394060A1 (fr)
AR (1) AR107164A1 (fr)
MA (1) MA44131A (fr)
WO (1) WO2017108738A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10364245B2 (en) * 2017-06-07 2019-07-30 Chiesi Farmaceutici S.P.A. Kinase inhibitors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
US6034057A (en) 1995-07-06 2000-03-07 Zeneca Limited Peptide inhibitors of fibronectine
US6248713B1 (en) 1995-07-11 2001-06-19 Biogen, Inc. Cell adhesion inhibitors
YU25500A (sh) 1999-05-11 2003-08-29 Pfizer Products Inc. Postupak za sintezu analoga nukleozida
GB0028383D0 (en) 2000-11-21 2001-01-03 Novartis Ag Organic compounds
EP1241176A1 (fr) 2001-03-16 2002-09-18 Pfizer Products Inc. Dérivés de purine pour le traitement de l'ischémie
DE60214428T2 (de) 2001-12-20 2007-09-20 Bayer Healthcare Ag 1, 4-dihydro-1, 4-diphenylpyridin-derivate
SE0302487D0 (sv) 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
GB0502258D0 (en) 2005-02-03 2005-03-09 Argenta Discovery Ltd Compounds and their use
TW200837064A (en) 2006-10-04 2008-09-16 Pharmacopeia Inc 8-substituted 2-(benzimidazolyl)purine derivatives for immunosuppression
UA115320C2 (uk) * 2011-12-09 2017-10-25 К'Єзі Фармачеутічі С.П.А. Інгібітори кінази
WO2014194956A1 (fr) * 2013-06-06 2014-12-11 Chiesi Farmaceutici S.P.A. Dérivés de [1, 2, 4] triazolo [4, 3 - a] pyridine utiles en tant qu'inhibiteurs de p38 - map kinase
EP3004098B1 (fr) 2013-06-06 2017-08-09 Chiesi Farmaceutici S.p.A. Inhibiteurs de kinase

Also Published As

Publication number Publication date
US20170183344A1 (en) 2017-06-29
WO2017108738A1 (fr) 2017-06-29
EP3394060A1 (fr) 2018-10-31
AR107164A1 (es) 2018-03-28
US9758521B2 (en) 2017-09-12

Similar Documents

Publication Publication Date Title
IL288104A (en) Heterocyclic compounds, preparation methods and uses thereof
EP3672973A4 (fr) Composés hétérocycliques utilisés en tant qu'inhibiteurs de kinase, compositions comprenant le composé hétérocyclique, et leurs procédés d'utilisation
CY1121831T1 (el) Παραγωγα θειενο [2,3-c] πυρρολ-4-ονης ως αναστολεις της erk
SG11202011513RA (en) Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof
EP3638229A4 (fr) Inhibiteurs de la kinase alk2 contenant de l'imidazole
SI3555070T1 (sl) Amino-substituirane heterociklične spojine kot inhibitorji ehmt2 in načini njihove uporabe
LT3523301T (lt) Pakeistieji pirazolo[1,5-a]piridino junginiai kaip ret kinazės slopikliai
EP3752491A4 (fr) Composés hétérocycliques utilisés en tant qu'inhibiteurs de kinases
MX382927B (es) Compuestos de benzolactama como inhibidores de la proteína cinasa.
MX382339B (es) Inhibidores g12c de kras.
LT3464272T (lt) Nauji heterocikliniai dariniai, naudingi kaip shp2 inhibitoriai
HUE053067T2 (hu) Helyettesített pirazolo[1,5-A]piridin vegyületek, mint RET kináz inhibitorok
MX2017012613A (es) Imidazolonilquinolinas y el uso de las mismas como inhibidores de cinasa atm.
EP3444254A4 (fr) Dérivé de pyridinopyrimidinone substitué hétérocyclique en tant qu'inhibiteur de cdk et son utilisation
MX381487B (es) Ciertos inhibidores de la proteina quinasa.
MA40774A (fr) Dérivés de diaryle-urée en tant qu'inhibiteurs de kinase p38
EP3728217C0 (fr) Dérivés de chroménopyridine utilisés en tant qu'inhibiteurs de la phosphatidylinositol phosphate kinase
UA111804C2 (uk) ПОХІДНІ ПІРОЛО[2,3-d]ПІРИМІДИНУ ЯК ІНГІБІТОРИ ЯНУС-ЗАЛЕЖНИХ КІНАЗ (JAK)
EA202091120A3 (ru) Производные 2,4-тиазолинидона в лечении расстройств центральной нервной системы
HUE057317T2 (hu) Helyettesített [1,2,4]triazolo[1,5-A]pirimidin-7-IL vegyületeket tartalmazó készítmények mint PDE2 inhibítorok
HUE048576T2 (hu) 1H-pirazolo[4,3B]piridinek, mint PDE1 inhibitorok
EA201790395A1 (ru) Производные аминотриазина, подходящие для применения в качестве соединений-ингибиторов tank-связывающей киназы
SI3609886T1 (sl) Analogi benzoazepina kot inhibicijska sredstva za brutonovo tirozin kinazo
EP3697791A4 (fr) Composés hétérocycliques, compositions comprenant le composé hétérocyclique, et leurs procédés d'utilisation
EP3684772C0 (fr) Dérivés d'iminopyrimidine cycliques utilisés en tant qu'inhibiteurs de kinases